TW237450B - - Google Patents
Info
- Publication number
- TW237450B TW237450B TW082110143A TW82110143A TW237450B TW 237450 B TW237450 B TW 237450B TW 082110143 A TW082110143 A TW 082110143A TW 82110143 A TW82110143 A TW 82110143A TW 237450 B TW237450 B TW 237450B
- Authority
- TW
- Taiwan
- Prior art keywords
- 4alkyl
- pct
- optionally substituted
- halogen
- phenyl
- Prior art date
Links
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 229910052757 nitrogen Inorganic materials 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- -1 amino, substituted amino, hydroxy Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- 125000003341 7 membered heterocyclic group Chemical group 0.000 abstract 1
- 102100021022 Gastrin Human genes 0.000 abstract 1
- 108010052343 Gastrins Proteins 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000005864 Sulphur Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000001715 oxadiazolyl group Chemical group 0.000 abstract 1
- 125000002971 oxazolyl group Chemical group 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929225492A GB9225492D0 (en) | 1992-12-05 | 1992-12-05 | Amine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW237450B true TW237450B (enExample) | 1995-01-01 |
Family
ID=10726205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW082110143A TW237450B (enExample) | 1992-12-05 | 1993-12-01 |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US5569654A (enExample) |
| EP (1) | EP0672037B1 (enExample) |
| JP (1) | JPH08504200A (enExample) |
| KR (1) | KR950704270A (enExample) |
| CN (1) | CN1093085A (enExample) |
| AT (1) | ATE168102T1 (enExample) |
| AU (1) | AU688295B2 (enExample) |
| BG (1) | BG99696A (enExample) |
| BR (1) | BR9307580A (enExample) |
| CA (1) | CA2150461A1 (enExample) |
| CZ (1) | CZ138495A3 (enExample) |
| DE (1) | DE69319614D1 (enExample) |
| EC (1) | ECSP941085A (enExample) |
| FI (1) | FI952709A7 (enExample) |
| GB (1) | GB9225492D0 (enExample) |
| HU (1) | HUT71339A (enExample) |
| IL (1) | IL107869A (enExample) |
| MX (1) | MX9307654A (enExample) |
| NO (1) | NO952208L (enExample) |
| NZ (1) | NZ258874A (enExample) |
| OA (1) | OA10161A (enExample) |
| PE (1) | PE54294A1 (enExample) |
| PL (1) | PL309281A1 (enExample) |
| RO (1) | RO114446B1 (enExample) |
| RU (1) | RU95114528A (enExample) |
| SK (1) | SK74195A3 (enExample) |
| TW (1) | TW237450B (enExample) |
| WO (1) | WO1994013648A1 (enExample) |
| ZA (1) | ZA939068B (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9314981D0 (en) * | 1993-07-20 | 1993-09-01 | Glaxo Spa | Chemical compounds |
| US5428157A (en) * | 1993-11-22 | 1995-06-27 | Merck & Co., Inc. | 3-acylaminobenzodiazepines |
| WO1995028399A1 (en) * | 1994-04-15 | 1995-10-26 | Glaxo Wellcome Inc. | A method of inducing cholecystokinin agonist activity using 1,4-benzodiazepine compounds |
| US5807876A (en) * | 1996-04-23 | 1998-09-15 | Vertex Pharmaceuticals Incorporated | Inhibitors of IMPDH enzyme |
| AUPO284396A0 (en) * | 1996-10-08 | 1996-10-31 | Fujisawa Pharmaceutical Co., Ltd. | Benzodiazepine derivatives |
| US6194435B1 (en) | 1996-10-11 | 2001-02-27 | Cor Therapeutics, Inc. | Lactams as selective factor Xa inhibitors |
| US6262047B1 (en) | 1996-10-11 | 2001-07-17 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| US6369080B2 (en) | 1996-10-11 | 2002-04-09 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| US6063794A (en) | 1996-10-11 | 2000-05-16 | Cor Therapeutics Inc. | Selective factor Xa inhibitors |
| EP0977772A1 (en) | 1997-04-14 | 2000-02-09 | Cor Therapeutics, Inc. | SELECTIVE FACTOR Xa INHIBITORS |
| US6369063B1 (en) | 1997-04-14 | 2002-04-09 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| AU747531B2 (en) | 1997-04-14 | 2002-05-16 | Millennium Pharmaceuticals, Inc. | Selective factor Xa inhibitors |
| US6228854B1 (en) | 1997-08-11 | 2001-05-08 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| US6333321B1 (en) * | 1997-08-11 | 2001-12-25 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| US6218382B1 (en) | 1997-08-11 | 2001-04-17 | Cor Therapeutics, Inc | Selective factor Xa inhibitors |
| US6100254A (en) * | 1997-10-10 | 2000-08-08 | Board Of Regents, The University Of Texas System | Inhibitors of protein tyrosine kinases |
| US20080058424A1 (en) * | 2002-05-23 | 2008-03-06 | Cephalon, Inc. | Novel pharmaceutical formulations of modafinil |
| US7297346B2 (en) * | 2001-05-25 | 2007-11-20 | Cephalon Inc. | Pharmaceutical formulations of modafinil |
| US7229644B2 (en) * | 2002-05-23 | 2007-06-12 | Cephalon, Inc. | Pharmaceutical formulations of modafinil |
| US20040116532A1 (en) * | 2002-09-13 | 2004-06-17 | Craig Heacock | Pharmaceutical formulations of modafinil |
| US7612200B2 (en) * | 2004-12-07 | 2009-11-03 | Locus Pharmaceuticals, Inc. | Inhibitors of protein kinases |
| WO2006062982A2 (en) * | 2004-12-07 | 2006-06-15 | Locus Pharmaceuticals, Inc. | Urea inhibitors of map kinases |
| CA2635888A1 (en) * | 2006-01-04 | 2007-07-19 | Locus Pharmaceuticals, Inc. | Inhibitors of protein kinases |
| GB201414116D0 (en) * | 2014-08-08 | 2014-09-24 | Trio Medicines Ltd | Benzodiazepine derivatives |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2032226A1 (en) * | 1989-12-18 | 1991-06-19 | Mark G. Bock | Benzodiazepine analogs |
| CA2068355A1 (en) * | 1991-05-14 | 1992-11-15 | Mark S. Chambers | Benzodiazephine derivatives, compositions containing them and their use in therapy |
| GB9201180D0 (en) * | 1992-01-21 | 1992-03-11 | Glaxo Group Ltd | Chemical compounds |
-
1992
- 1992-12-05 GB GB929225492A patent/GB9225492D0/en active Pending
-
1993
- 1993-12-01 TW TW082110143A patent/TW237450B/zh active
- 1993-12-02 RO RO95-01064A patent/RO114446B1/ro unknown
- 1993-12-02 PL PL93309281A patent/PL309281A1/xx unknown
- 1993-12-02 NZ NZ258874A patent/NZ258874A/en unknown
- 1993-12-02 WO PCT/EP1993/003381 patent/WO1994013648A1/en not_active Ceased
- 1993-12-02 BR BR9307580A patent/BR9307580A/pt not_active Application Discontinuation
- 1993-12-02 CA CA002150461A patent/CA2150461A1/en not_active Abandoned
- 1993-12-02 CZ CZ951384A patent/CZ138495A3/cs unknown
- 1993-12-02 SK SK741-95A patent/SK74195A3/sk unknown
- 1993-12-02 RU RU95114528/04A patent/RU95114528A/ru unknown
- 1993-12-02 KR KR1019950702269A patent/KR950704270A/ko not_active Withdrawn
- 1993-12-02 DE DE69319614T patent/DE69319614D1/de not_active Expired - Lifetime
- 1993-12-02 JP JP6513738A patent/JPH08504200A/ja active Pending
- 1993-12-02 AU AU56948/94A patent/AU688295B2/en not_active Ceased
- 1993-12-02 AT AT94902658T patent/ATE168102T1/de not_active IP Right Cessation
- 1993-12-02 HU HU9501622A patent/HUT71339A/hu unknown
- 1993-12-02 EP EP94902658A patent/EP0672037B1/en not_active Expired - Lifetime
- 1993-12-02 US US08/446,728 patent/US5569654A/en not_active Expired - Fee Related
- 1993-12-03 ZA ZA939068A patent/ZA939068B/xx unknown
- 1993-12-03 MX MX9307654A patent/MX9307654A/es not_active IP Right Cessation
- 1993-12-03 IL IL10786993A patent/IL107869A/en active IP Right Review Request
- 1993-12-04 CN CN93120779A patent/CN1093085A/zh active Pending
-
1994
- 1994-05-11 EC EC1994001085A patent/ECSP941085A/es unknown
- 1994-06-01 PE PE1994243670A patent/PE54294A1/es not_active Application Discontinuation
-
1995
- 1995-05-30 OA OA60669A patent/OA10161A/en unknown
- 1995-06-02 BG BG99696A patent/BG99696A/bg unknown
- 1995-06-02 FI FI952709A patent/FI952709A7/fi not_active Application Discontinuation
- 1995-06-02 NO NO952208A patent/NO952208L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO952208L (no) | 1995-08-02 |
| ZA939068B (en) | 1994-08-09 |
| KR950704270A (ko) | 1995-11-17 |
| AU688295B2 (en) | 1998-03-12 |
| JPH08504200A (ja) | 1996-05-07 |
| DE69319614D1 (de) | 1998-08-13 |
| EP0672037B1 (en) | 1998-07-08 |
| RO114446B1 (ro) | 1999-04-30 |
| FI952709A0 (fi) | 1995-06-02 |
| NZ258874A (en) | 1996-09-25 |
| OA10161A (en) | 1996-12-18 |
| IL107869A0 (en) | 1994-04-12 |
| CA2150461A1 (en) | 1994-06-23 |
| WO1994013648A1 (en) | 1994-06-23 |
| CN1093085A (zh) | 1994-10-05 |
| FI952709A7 (fi) | 1995-08-01 |
| PL309281A1 (en) | 1995-10-02 |
| EP0672037A1 (en) | 1995-09-20 |
| AU5694894A (en) | 1994-07-04 |
| US5569654A (en) | 1996-10-29 |
| BG99696A (bg) | 1996-01-31 |
| GB9225492D0 (en) | 1993-01-27 |
| BR9307580A (pt) | 1999-06-29 |
| SK74195A3 (en) | 1995-11-08 |
| HUT71339A (en) | 1995-11-28 |
| PE54294A1 (es) | 1995-01-06 |
| RU95114528A (ru) | 1997-06-10 |
| MX9307654A (es) | 1994-06-30 |
| ATE168102T1 (de) | 1998-07-15 |
| CZ138495A3 (en) | 1995-12-13 |
| NO952208D0 (no) | 1995-06-02 |
| ECSP941085A (es) | 1994-12-15 |
| HU9501622D0 (en) | 1995-08-28 |
| IL107869A (en) | 1998-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA939068B (en) | Amine derivatives | |
| CO4970780A1 (es) | Nuevos compuestos heterociclicos de piridazina | |
| DK0590919T3 (da) | Terapeutiske midler mod Parkinsons sygdom | |
| UA72917C2 (en) | Cyclic carbamates derivatives, pharmaceutical composition containing said derivatives of cyclic carbamates and active ingredients as modulators of the progesterone receptor | |
| NZ503076A (en) | 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives and addition salts thereof, with antagonism against amino acid receptors (particularly AMPA receptor) and processes for their preparation | |
| YU151691A (sh) | 3-aril-4(3h)hinazolinon cck antagonisti | |
| FI931707A0 (fi) | 1,2,4-oxadiazolyl-fenoxialkylisoxazoler och deras anvaendning som virusmotarbetande aemnen | |
| IL104567A (en) | Ethanolamine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| ID18181A (id) | Senyawa-senyawa baru | |
| BG97221A (bg) | Ортозаместени бифениламидини и бифенилизанидини и съдържащите ги антидиабетични или хипогликемични средства | |
| DE69206274D1 (de) | 3-ureido-benzodiazepinone verwendbar als cck- oder gastrin-antagonisten. | |
| DK0759027T3 (da) | Bicykliske amidinderivater som inhibitorer af nitrogenoxidsynthetase | |
| MY118638A (en) | 1,5-benzodiazepine derivatives | |
| ATE251117T1 (de) | Neue aminobenzophenone | |
| DE69520279D1 (de) | Bibphenylamid-derivate als 5-ht1d-antagonisten | |
| CO5540322A2 (es) | Nuevos derivados heterociclicos que comprenden un anillo de tetrahidroisoquinolina y uso farmaceutico de los mismos | |
| ATE172454T1 (de) | Pyridazinon derivate mit pharmazeutischer wirkung | |
| DK1220848T3 (da) | N-arylmethylthioanilid-forbindelser, som er nyttige til inhibition af replikationen af HIV | |
| ATE191465T1 (de) | Carbamoylcarbonsäureamide | |
| ES2010089A6 (es) | Procedimiento para la obtencion de n-oxidos de gamma-carbolina antipsicoticos. | |
| NO870251D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazopyridiner. | |
| GB9315018D0 (en) | Chemical compounds | |
| ECSP920822A (es) | Composiciones heterocyclicas | |
| HK1043991A1 (zh) | 作為黃體酮受體調節劑的喹唑啉酮及苯並噁嗪衍生物 | |
| BG96022A (bg) | 2-(2'метил-3',4'-тризаместени бензол)-1,3- циклохександиони, метод за борба срещу нежелана растителност и хербициден състав, използващ тези съединения |